| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
|
Caocci, G.
|
|
2015
|
39 |
8 |
p. 859-865
7 p.
|
artikel
|
| 2 |
Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes
|
Balleari, E.
|
|
2015
|
39 |
8 |
p. 846-852
7 p.
|
artikel
|
| 3 |
Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcome
|
Masarova, Lucia
|
|
2015
|
39 |
8 |
p. 822-827
6 p.
|
artikel
|
| 4 |
Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN
|
Andriani, Alessandro
|
|
2015
|
39 |
8 |
p. 801-804
4 p.
|
artikel
|
| 5 |
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes
|
Minetto, Paola
|
|
2015
|
39 |
8 |
p. 866-873
8 p.
|
artikel
|
| 6 |
Corrigendum to ‘Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias’ [Leuk. Res. 39(2) (2015) 242–247]
|
Burmeister, Thomas
|
|
2015
|
39 |
8 |
p. 925-
1 p.
|
artikel
|
| 7 |
Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles
|
Ramos, Teresa L.
|
|
2015
|
39 |
8 |
p. 921-924
4 p.
|
artikel
|
| 8 |
Editorial board and publication information
|
|
|
2015
|
39 |
8 |
p. IFC-
1 p.
|
artikel
|
| 9 |
High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells
|
Numata, Masashi
|
|
2015
|
39 |
8 |
p. 906-912
7 p.
|
artikel
|
| 10 |
HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: Significant correlation with relapse and overall survival
|
Adamaki, Maria
|
|
2015
|
39 |
8 |
p. 874-882
9 p.
|
artikel
|
| 11 |
Hyperferritinemia at diagnosis predicts relapse and overall survival in younger AML patients with intermediate-risk cytogenetics
|
Lebon, Delphine
|
|
2015
|
39 |
8 |
p. 818-821
4 p.
|
artikel
|
| 12 |
Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia
|
Liu, Limin
|
|
2015
|
39 |
8 |
p. 805-811
7 p.
|
artikel
|
| 13 |
Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome
|
Bastida, J.M.
|
|
2015
|
39 |
8 |
p. 828-834
7 p.
|
artikel
|
| 14 |
miR-155 regulative network in FLT3 mutated acute myeloid leukemia
|
Salemi, Domenico
|
|
2015
|
39 |
8 |
p. 883-896
14 p.
|
artikel
|
| 15 |
Novel CT domain-encoding splice forms of CTGF/CCN2 are expressed in B-lineage acute lymphoblastic leukaemia
|
Welch, M.D.
|
|
2015
|
39 |
8 |
p. 913-920
8 p.
|
artikel
|
| 16 |
Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy
|
Rudrapatna, Venkatesh K.
|
|
2015
|
39 |
8 |
p. 835-839
5 p.
|
artikel
|
| 17 |
Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study
|
Reagan, John L.
|
|
2015
|
39 |
8 |
p. 812-817
6 p.
|
artikel
|
| 18 |
STAT5A regulates DNMT3A in CD34+/CD38− AML cells
|
Takeuchi, Asako
|
|
2015
|
39 |
8 |
p. 897-905
9 p.
|
artikel
|
| 19 |
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment
|
Morabito, Fortunato
|
|
2015
|
39 |
8 |
p. 840-845
6 p.
|
artikel
|
| 20 |
The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment
|
Sancho, Juan-Manuel
|
|
2015
|
39 |
8 |
p. 853-858
6 p.
|
artikel
|
Tijdschrift beschrijving